Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1975 Jan;11(1):42–51. doi: 10.1128/iai.11.1.42-51.1975

Antibody response to Epstein-Barr virus in infectious mononucleosis.

J Nikoskelainen, P Hänninen
PMCID: PMC415022  PMID: 163790

Abstract

Altogether 171 serum specimens from 58 patients with heterophil antibody-positive infectious monomucleosis were studied for antibody response to Epstein-Barr virus (EBV). The sera were tested for fluorescent immunoglobulin G (IgG) and IgM gel-precipitating (GP) and complement-fixing (CF) antibodies to EBV. All 58 patients had IgG and IgM antibodies to EBV. Both IgG and IgM antibodies developed rapidly; the IgM antibodies disappeared within 8 to 10 weeks, whereas the IgG antibodies remained at an almost constant level. The development of IgG antibodies was so rapid that a fourfold or greater rise in titers was noted only in 22% of the patients. Both GP and CF antibodies to EBV (crude P3HR-1 Burkitt cell antigen) developed slowly; the mean titers kept rising for more than 12 weeks. The micro GP technique seemed to be more sensitive than the CF method, because 86% of the patients with infectious mononucleosis had GP antibodies compared with 72% having CF antibodies. In patients with infectious mononucleosis, a seroconversion or significant rise in GP antibodies was noted in 57%, whereas only 19% had a similar change in CF antibodies. The most promising of these antibody assays in the diagnosis of recent infections was the EBV-specific IgM antibody technique, which enables one to make the diagnosis on the basis of only one serum specimen. In cases where the acute-phase serum specimen is missing, the diagnosis can be made later by using the GP and CF techniques.

Full text

PDF
42

Images in this article

45Image
on p.45
46Image
on p.46
48Image
on p.48
48Image
on p.48
49Image
on p.49

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Achong B. G. EB virus in relation to tumours. J Clin Pathol Suppl (R Coll Pathol) 1972;6:51–57. [PMC free article] [PubMed] [Google Scholar]
  2. Banatvala J. E., Best J. M., Waller D. K. Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma. Lancet. 1972 Jun 3;1(7762):1205–1208. doi: 10.1016/s0140-6736(72)90925-7. [DOI] [PubMed] [Google Scholar]
  3. DAVIDSOHN I., LEE C. L. SEROLOGIC DIAGNOSIS OF INFECTIOUS MONONUCLEOSIS. A COMPARATIVE STUDY OF FIVE TESTS. Am J Clin Pathol. 1964 Feb;41:115–125. doi: 10.1093/ajcp/41.2.115. [DOI] [PubMed] [Google Scholar]
  4. Evans A. S., Rothfield N. F., Niederman J. C. Raised antibody titres to E.B. virus in systemic lupus erythematosus. Lancet. 1971 Jan 23;1(7691):167–168. doi: 10.1016/s0140-6736(71)91937-4. [DOI] [PubMed] [Google Scholar]
  5. Fraser K. B., Shirodaria P. V., Stanford C. F. Fluorescent staining and human IgM. Br Med J. 1971 Sep 18;3(5776):707–707. doi: 10.1136/bmj.3.5776.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Henle G., Henle W. Observations on childhood infections with the Epstein-Barr virus. J Infect Dis. 1970 Mar;121(3):303–310. doi: 10.1093/infdis/121.3.303. [DOI] [PubMed] [Google Scholar]
  8. Henle W., Henle G. Epstein-Barr virus and infectious mononucleosis. N Engl J Med. 1973 Feb 1;288(5):263–264. doi: 10.1056/NEJM197302012880512. [DOI] [PubMed] [Google Scholar]
  9. Hewetson J. F., Rocchi G., Henle W., Henle G. Neutralizing antibodies to Epstein-Barr virus in healthy populations and patients with infectious mononucleosis. J Infect Dis. 1973 Sep;128(3):283–289. doi: 10.1093/infdis/128.3.283. [DOI] [PubMed] [Google Scholar]
  10. Hinuma Y., Konn M., Yamaguchi J., Wudarski D. J., Blakeslee J. R., Jr, Grace J. T., Jr Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J Virol. 1967 Oct;1(5):1045–1051. doi: 10.1128/jvi.1.5.1045-1051.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hopsu-Havu V. K., Nikoskelainen J. Epstein-Barr virus antibody titres in mycosis fungoides. Acta Derm Venereol. 1972;52(5):346–348. [PubMed] [Google Scholar]
  12. Joncas J. H. Clinical significance of the EB herpesvirus infection in man. Prog Med Virol. 1972;14:200–240. [PubMed] [Google Scholar]
  13. Klemola E., Von Essen R., Henle G., Henle W. Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies. J Infect Dis. 1970 Jun;121(6):608–614. doi: 10.1093/infdis/121.6.608. [DOI] [PubMed] [Google Scholar]
  14. Nikoskelainen J., Hannuksela M., Palva T. Antibodies to Epstein-Barr virus and some other herpesviruses in patients with sarcoidosis, pulmonary tuberculosis and erythema nodosum. Scand J Infect Dis. 1974;6(3):209–216. doi: 10.3109/inf.1974.6.issue-3.01. [DOI] [PubMed] [Google Scholar]
  15. Pyrhönen S., Penttinen K. Wart-virus antibodies and the prognosis of wart disease. Lancet. 1972 Dec 23;2(7791):1330–1332. doi: 10.1016/s0140-6736(72)92776-6. [DOI] [PubMed] [Google Scholar]
  16. SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
  17. Salmi A. A. Gel precipitation reactions between alkaline extracted rubella antigens and human sera. Acta Pathol Microbiol Scand. 1969;76(2):271–278. doi: 10.1111/j.1699-0463.1969.tb03257.x. [DOI] [PubMed] [Google Scholar]
  18. Schmitz H., Scherer M. IgM antibodies to Epstein-Barr virus in infectious mononucleosis. Arch Gesamte Virusforsch. 1972;37(4):332–339. doi: 10.1007/BF01241456. [DOI] [PubMed] [Google Scholar]
  19. Shirodaria P. V., Fraser K. B., Stanford F. Secondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti-IgM. Ann Rheum Dis. 1973 Jan;32(1):53–57. doi: 10.1136/ard.32.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sutton R. N., Almond E. J., Marston S. D., Emond R. T. Complement-fixing and fluorescent antibodies in diagnosis of E.B.-virus infections. Lancet. 1971 Nov 13;2(7733):1095–1095. doi: 10.1016/s0140-6736(71)90415-6. [DOI] [PubMed] [Google Scholar]
  21. Wager O., Räsänen J. A., Hagman A., Klemola E. Mixed cryoimmunoglobulinaemia in infectious mononucleois and Cytomegalovirus mononucleosis. Int Arch Allergy Appl Immunol. 1968;34(4):345–361. doi: 10.1159/000230129. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES